TOP TIERMARKET NEWSWIRE
SEC Form 4 history

PHIO PHARMACEUTICALS Equity (PHIO) insider trades

PHIO PHARMACEUTICALS Equity (PHIO) insider trading activity (SEC Form 4). Over the trailing 90 days, PHIO insiders filed 9 purchases totalling $105K and 0 sales totalling $0 — net BUYING of $105K. Most recent filing: Nov 12, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
9
$105K
Sells (90d)
0
$0
Net (90d)
+$105K
net buying
Most recent
Nov 12, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 12, 2026Deming David HDirP Purchase—$0.84$10Kfiling
Nov 10, 2026Plott Ronald ToddDirP Purchase—$0.83$15Kfiling
Nov 10, 2026Bitterman Robert JCOB, Pres, CEOP Purchase—$0.82$21Kfiling
Sep 30, 2026Plott Ronald ToddDirP Purchase—$1.04$10Kfiling
Sep 25, 2026Bradford Patricia ADirP Purchase—$1.01$7Kfiling
Sep 23, 2026Bitterman Robert JCOB, Pres, CEOP Purchase—$1.03$2Kfiling
Sep 16, 2026Bradford Patricia ADirP Purchase—$1.03$12Kfiling
Aug 20, 2026Plott Ronald ToddDirP Purchase—$1.14$17Kfiling
Aug 19, 2026Bitterman Robert JCOB, Pres, CEOP Purchase—$1.06$11Kfiling
Jun 29, 2026Bitterman Robert JCOB, Pres, CEOP Purchase—$0.99$10Kfiling